Martin Bauer - Concepedia

Author

Martin Bauer

Also Known As

Bauer, M, Cherubin, Pierre, Clemens Tesch-Römer, E. M. Pollabauer, E.M. Pöllabauer, Eva Maria Pöllabauer, Eva Pöllabauer, Eva Maria Pöllabauer, M BAUER, M Bauer

151

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Austrian Institute of Technology University of Vienna Inserm Université Paris-Saclay

About

Martin Bauer is an author at Medical University of Vienna specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	507
2	Health Sciences	4	4	129
3	Engineering	2	2	128
4	Natural Sciences	1	1	15
5	Social Sciences	1	1	180

Martin Bauer

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Blood–brain barrier P-glycoprotein function in Alzheimer's disease Daniëlle M. E. van Assema, Mark Lubberink, Martin Bauer, Brain	2011	304
P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study M Feldmann, Marie-Claude Asselin, Joan Liu, The Lancet Neurology NeuropsychologyNeurophysiologyTemporal Lobe EpilepsyClinical NeuroscienceNeuroscience	2013	180
Pharmacoresistance in Epilepsy: A Pilot PET Study with the P‐Glycoprotein Substrate<i>R</i>‐[<sup>11</sup>C]verapamil Oliver Langer, Martin Bauer, Alexander Hammers, Epilepsia	2007	139
Pgp-Mediated Interaction Between (R)-[11C]Verapamil and Tariquidar at the Human Blood–Brain Barrier: A Comparison With Rat Data Martin Bauer, Markus Zeitlinger, Rudolf Karch, Clinical Pharmacology & Therapeutics	2011	118
A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood–Brain Barrier with (<i>R</i>)-<sup>11</sup>C-Verapamil and PET Cláudia Wagner, Martin Bauer, Rudolf Karch, Journal of Nuclear Medicine	2009	111
Psychopathological Correlates of Reduced Dopamine Receptor Sensitivity in Depression, Schizophrenia, and Opiate and Alcohol Dependence12 Karl T. Schmidt, B. Nolte-Zenker, J Patzer, Pharmacopsychiatry	2001	96
Limitations of Small Animal PET Imaging with [18F]FDDNP and FDG for Quantitative Studies in a Transgenic Mouse Model of Alzheimer’s Disease Claudia Kuntner, Adam Kesner, Martin Bauer, Molecular Imaging and Biology Positron Emission TomographyNeurodegenerative DiseasesQuantitative StudiesAlzheimer's DiseaseEngineering	2009	93
Approaching Complete Inhibition of P-Glycoprotein at the Human Blood–Brain Barrier: An (<i>R</i>)-[<sup>11</sup>C]Verapamil PET Study Martin Bauer, Rudolf Karch, Markus Zeitlinger, Journal of Cerebral Blood Flow & Metabolism	2015	88
Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET Martin Bauer, Rudolf Karch, Friederike Neumann, European Journal of Clinical Pharmacology AgingNeurophysiologyMedicineDementiaPhysiology	2009	64
Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood–Brain Barrier Martin Bauer, Kerstin Römermann, Rudolf Karch, Clinical Pharmacology & Therapeutics	2016	58

Page 1